|Bid||3.22 x 500|
|Ask||3.33 x 5000|
|Day's Range||3.21 - 3.30|
|52 Week Range||2.26 - 4.01|
|PE Ratio (TTM)||3.36|
|Earnings Date||Aug 7, 2017 - Aug 11, 2017|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||5.83|
Categories: Europe Stock Alerts Yahoo FinanceClick here to see latest analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for BioTime, Inc.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bullish Closing Price above/below 200 Day Moving Average ... Read more (Read more...)
BioTime, Inc. , a clinical-stage biotechnology company developing and commercializing products addressing degenerative diseases, today announced that Co-Chief Executive Officer Michael D.
BioTime, Inc. , a clinical-stage biotechnology company developing and commercializing products addressing degenerative diseases, today announced that BioTime, and its subsidiary Cell Cure Neurosciences Ltd., will be featured in two presentations at the 16th National Life Sciences and Biotechnology Week on Wednesday, May 24, 2017 as part of the Regenerative and Cell Therapies track.